Tradjenta (linagliptin) Tablets

Tradjenta is a prescription tablet used to improve blood glucose control in adults with type 2 diabetes. It is commonly used alone or with other non-insulin medicines alongside diet and activity. This page covers how it works, dosage basics, storage, safety, and access details for cash-pay patients without insurance.

For eligible prescriptions, US shipping from Canada is available; requirements vary by medication.

The sections below summarize practical handling points and key label-based safety topics to review with a healthcare professional.

What Tradjenta Is and How It Works

Linagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor, a class that supports incretin hormones (gut hormones) involved in blood sugar control. Ships from Canada to US availability depends on prescription validation and pharmacy policies. Prescription details can be confirmed with your prescriber when required. For related medicines in the same class, browse the Dpp 4 Inhibitors hub.

This treatment works by blocking the DPP-4 enzyme, which helps increase active incretin levels after meals. Incretins can raise insulin release and lower glucagon (a hormone that signals the liver to release sugar) in a glucose-dependent way, meaning effects are tied to higher glucose levels. The result may be lower fasting and after-meal glucose when combined with lifestyle measures and, when needed, other glucose-lowering therapies.

Why it matters: Glucose-dependent effects may reduce low-sugar risk when used alone.

Who It’s For

This medicine is indicated for adults with type 2 diabetes to improve glycemic control, usually as an add-on to diet and exercise. Tradjenta may be used by itself or combined with other glucose-lowering drugs when a clinician determines additional control is needed. Background information on the condition is available in the Type 2 Diabetes resource area.

It is not used for type 1 diabetes and is not a treatment for diabetic ketoacidosis. People with a history of serious hypersensitivity (allergic reaction) to linagliptin should not use it. Extra caution is typically discussed for those with a history of pancreatitis (pancreas inflammation), complex medication regimens, or pregnancy and breastfeeding considerations. For a broader browseable list of diabetes-related items, see the Diabetes Category hub.

Dosage and Usage

Label-based dosing for linagliptin is 5 mg by mouth once daily, taken with or without food. The tablet is typically swallowed whole with water. If a dose is missed, standard labeling instructions generally advise taking the next dose at the usual time and not doubling up.

While linagliptin is known for not requiring dose adjustment in renal impairment, kidney function still matters for overall diabetes medication planning and monitoring. Tradjenta dosing should follow the prescriber’s directions and the official product label, especially when used with other agents that can cause hypoglycemia. To understand how fixed-dose combinations that include linagliptin are typically scheduled, see Jentadueto Uses Dosage. For other non-injectable options commonly paired with lifestyle measures, browse Non Insulin Medications.

Strengths and Forms

Linagliptin is supplied as an oral tablet. The standard presentation is a 5 mg tablet intended for once-daily dosing. Availability can differ across pharmacies and jurisdictions, and packaging may vary between manufacturers and markets.

Licensed Canadian pharmacies dispense orders after prescription review. For practical reference, the table below summarizes the usual form and schedule that appear on many labels, while emphasizing that the prescriber’s instructions control.

Storage and Travel Basics

Store tablets at room temperature in a dry place, protected from moisture. Keep the medicine in its original container until use, and avoid storing it where heat and humidity are high (for example, a bathroom cabinet). If a desiccant is included in the bottle, it is intended to help control moisture.

For travel, keep the medication in carry-on baggage when possible and retain the prescription label for identification. Temperature swings in cars and checked luggage can be significant, so stable room-temperature handling is usually preferred. When crossing time zones, people often discuss with their clinician how to keep a consistent once-daily routine without taking doses too close together.

Side Effects and Safety

Common side effects reported with DPP-4 inhibitors can include upper respiratory symptoms (such as runny nose or sore throat), cough, and headache. Gastrointestinal effects may occur in some people, and laboratory changes can happen depending on other therapies. Tradjenta can increase the risk of hypoglycemia when used with insulin or a sulfonylurea, because those medicines lower glucose independently.

Serious reactions are less common but important to recognize promptly. These can include pancreatitis (pancreas inflammation), severe hypersensitivity (allergic reaction) such as angioedema (rapid swelling), severe joint pain, and bullous pemphigoid (a blistering skin condition). Seek urgent medical care for severe abdominal pain (with or without vomiting), facial or throat swelling, widespread rash, or blistering skin. For a general discussion of another DPP-4 inhibitor used for type 2 diabetes, see Nesina For Type 2.

Quick tip: Keep an up-to-date medication list for interaction checks.

Drug Interactions and Cautions

Medication review matters because some drugs can reduce linagliptin exposure. Strong inducers of P-gp and CYP3A4 (for example, rifampin) may lower effectiveness, and prescribers may consider alternatives. Tradjenta is also used alongside other glucose-lowering agents, so clinicians commonly reassess overall hypoglycemia risk when therapies are combined.

Share all prescription drugs, over-the-counter products, and supplements with the dispensing pharmacy and prescriber. Caution topics may include prior pancreatitis, complex comorbidities, and any history of serious allergic reactions. When diabetes therapy includes multiple agents, periodic monitoring of glucose patterns and A1C (a longer-term glucose marker) is typically used to evaluate response and guide adjustments.

Compare With Alternatives

DPP-4 inhibitors include sitagliptin, saxagliptin, alogliptin, and linagliptin. These medicines are often considered when an oral, generally weight-neutral option is preferred and when treatment goals do not require insulin. Some products combine a DPP-4 inhibitor with metformin in a single tablet, which can simplify dosing for certain regimens.

Choosing among options depends on patient-specific factors such as kidney function, drug interactions, cardiovascular history, and tolerance of other therapies. For related product pages, see Januvia Product Details and Onglyza Product Details. For additional background reading, these guides may help frame a discussion with a prescriber: Januvia Uses and Correct Onglyza Dosage.

Pricing and Access

Out-of-pocket totals vary based on dispensing pharmacy, quantity, and whether a brand or an authorized equivalent is supplied. Tradjenta costs can also differ depending on the broader regimen, because combination therapy may change the total number of prescriptions filled each month. Cash-pay access is available for people without insurance coverage.

CanadianInsulin facilitates prescription referral and coordination with dispensing pharmacies rather than directly dispensing medication. For site-wide updates that may affect overall costs on eligible items, review Current Promotions. Documentation requirements and refill timing depend on the prescription and applicable pharmacy rules.

Authoritative Sources

The links below provide neutral, label-based information for clinical detail and safety updates.

• For U.S. regulatory drug information, see Drugs@FDA application overview.
• For patient-focused safety and use instructions, see MedlinePlus linagliptin monograph.

At checkout, select prompt, express, cold-chain shipping when available for temperature-sensitive items.

This content is for informational purposes only and is not a substitute for professional medical advice.